Search research articles
Contact Us
Filters
Showing results (211-220 of 391) with videos related to
Page
of 40
Sort By:
The Journal of Antibiotics
|
March 21, 2000
A new antifungal macrolide component, brasilinolide B, produced by Nocardia brasiliensis
Y Mikami, H Komaki, T Imai, et al.
The Journal of Antibiotics
|
May 29, 1999
Inactivation of fusidic acid by pathogenic Nocardia
K Harada, K Tomita, K Fujii, et al.
Diseases of the Colon and Rectum
|
May 27, 1999
Ratio of primary and secondary bile acids in feces: possible marker for colorectal cancer?
T Kamano, Y Mikami, T Kurasawa, et al.
Lancet (London, England)
|
September 17, 1994
Mediation of renal cyst formation by hepatocyte growth factor
S Horie, E Higashihara, K Nutahara, et al.
Cell
|
December 1, 1995
Atomic model of a pyrimidine dimer excision repair enzyme complexed with a DNA substrate: structural basis for damaged DNA recognition
D G Vassylyev, T Kashiwagi, Y Mikami, et al.
The Journal of Antibiotics
|
June 1, 1988
Structural studies on minor components of saframycin group antibiotics saframycins F, G and H
Y Mikami, K Takahashi, K Yazawa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Characterization of a neu/c-erbB-2 protein-specific activating factor
K Dobashi, J G Davis, Y Mikami, et al.
The Journal of Antibiotics
|
November 1, 1995
Structure determination of ribosylated rifampicin and its derivative: new inactivated metabolites of rifampicin by mycobacterial strains
N Morisaki, H Kobayashi, S Iwasaki, et al.
Mycopathologia
|
October 31, 2008
Dermatophyte infections in Cairo, Egypt
S M Zaki, N Ibrahim, K Aoyama, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1995
Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation
E R Dabbs, K Yazawa, Y Mikami, et al.
Page
of 40
Search research articles
Search
Showing results (211-220 of 391) with videos related to
Sort By:
Page
of 40
The Journal of Antibiotics
|
March 21, 2000
A new antifungal macrolide component, brasilinolide B, produced by Nocardia brasiliensis
Y Mikami, H Komaki, T Imai, et al.
The Journal of Antibiotics
|
May 29, 1999
Inactivation of fusidic acid by pathogenic Nocardia
K Harada, K Tomita, K Fujii, et al.
Diseases of the Colon and Rectum
|
May 27, 1999
Ratio of primary and secondary bile acids in feces: possible marker for colorectal cancer?
T Kamano, Y Mikami, T Kurasawa, et al.
Lancet (London, England)
|
September 17, 1994
Mediation of renal cyst formation by hepatocyte growth factor
S Horie, E Higashihara, K Nutahara, et al.
Cell
|
December 1, 1995
Atomic model of a pyrimidine dimer excision repair enzyme complexed with a DNA substrate: structural basis for damaged DNA recognition
D G Vassylyev, T Kashiwagi, Y Mikami, et al.
The Journal of Antibiotics
|
June 1, 1988
Structural studies on minor components of saframycin group antibiotics saframycins F, G and H
Y Mikami, K Takahashi, K Yazawa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Characterization of a neu/c-erbB-2 protein-specific activating factor
K Dobashi, J G Davis, Y Mikami, et al.
The Journal of Antibiotics
|
November 1, 1995
Structure determination of ribosylated rifampicin and its derivative: new inactivated metabolites of rifampicin by mycobacterial strains
N Morisaki, H Kobayashi, S Iwasaki, et al.
Mycopathologia
|
October 31, 2008
Dermatophyte infections in Cairo, Egypt
S M Zaki, N Ibrahim, K Aoyama, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1995
Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation
E R Dabbs, K Yazawa, Y Mikami, et al.
Page
of 40